ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,109, issued on Oct. 20, was assigned to The Trustees of Boston College (Chestnut Hill, Mass.).
"Sugar-coated melanin nanoparticles and method for targeting metastatic cancer cells" was invented by Krzysztof Kempa (Chestnut Hill, Mass.) and Michael J Naughton (Waltham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a method for the cellular uptake of sugar-coated melanin nanoparticles by metastatic cancer cells followed by illumination with nonionizing radiation (e.g., visible or IR light) causing cell death."
The patent was filed on March 16, 2023, under Application No. 18/122,221.
*For further information, including images, cha...